Get started
Author

Richard Vargas

Observed name: Vargas, Richard
OpenAlex ID: A5061596482
Discovery of Clinical Candidate 1-{[(2 S ,3 S ,4 S )-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design
2017 · Katherine L. Lee, Catherine M. Ambler, et al. · Journal of Medicinal Chemistry · 152
Benzenesulfonamide indole inhibitors of cytosolic phospholipase A2α: Optimization of in vitro potency and rat pharmacokinetics for oral efficacy
2007 · Katherine L. Lee, Mark L. Behnke, et al. · Bioorganic & Medicinal Chemistry · 28
Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical Trial
2024 · Meghan E Sise, Jose Ramon Santos, et al. · Clinical Infectious Diseases · 21
Abstract 2306: BLU-222, an investigational, potent, and selective CDK2 inhibitor, demonstrated robust antitumor activity in CCNE1-amplified ovarian cancer models
2022 · Victoria Brown, Phil Ramsden, et al. · Cancer Research · 14
Abstract 1279: Development of a selective CDK2-E inhibitor in CCNE driven cancers
2021 · Yoon J. Choi, Steve Wenglowsky, et al. · Cancer Research · 7
CCDC 1566948: Experimental Crystal Structure Determination
2017 · Lee, Katherine L., Ambler, Catherine M., et al. · The Cambridge Structural Database
CCDC 1566946: Experimental Crystal Structure Determination
2017 · Lee, Katherine L., Ambler, Catherine M., et al. · The Cambridge Structural Database
CCDC 1566947: Experimental Crystal Structure Determination
2017 · Lee, Katherine L., Ambler, Catherine M., et al. · The Cambridge Structural Database
CCDC 1566949: Experimental Crystal Structure Determination
2017 · Lee, Katherine L., Ambler, Catherine M., et al. · The Cambridge Structural Database
Works count: 9
Citation count: 221
H-index: 5
I10-index: 4
Year
Topic
Type